Therapeutic effects of lignans in women in perimenopausal and postmenopausal periods (review of literature)
| Autor: | Valentina V. Litvinova, Lyudmila A. Ozolinya |
|---|---|
| Rok vydání: | 2021 |
| Předmět: |
0301 basic medicine
Alternative methods Antitumor activity Pediatrics medicine.medical_specialty 030219 obstetrics & reproductive medicine business.industry Incidence (epidemiology) Therapeutic effect medicine.disease Menopause 03 medical and health sciences 030104 developmental biology 0302 clinical medicine Medicine Climacteric syndrome Climacteric business Metabolic profile |
| Zdroj: | V.F.Snegirev Archives of Obstetrics and Gynecology. 8:26-34 |
| ISSN: | 2313-8726 |
| Popis: | Today, there is a tendency towards an increase of the number of the female population that has crossed the line of menopause, which makes it more urgent to improve the quality of life of women and to develop safe methods for the prevention and treatment of climacteric syndrome (CS), which is an integral medical, social and economic problems. In view of the presence of contraindications for use and defined risks of complications with the use of hormone menopausal therapy (HRT), it is necessary to develop alternative methods for the prevention and treatment of perimenopausal symptoms. This literary review of domestic and foreign sources demonstrates information about the role of the plant lignan 7-hydroxymatairezinol (7-HMR) in maintaining the physical and psychoemotional health of women in the period of peri- and postmenopause. As a result of the analysis of the therapeutic effects of the 7-HMR molecule, the ability to relieve the main symptoms of CS (neurovegetative presentations and emotional disorders), to improve the general state of health and metabolic profile of perimenopausal women was revealed. High safety and low incidence of side effects were noted, as well as a positive effect on the dynamics of body weight. The presence of a stable anti-inflammatory and antioxidant activity 7-HMR makes it possible to recommend this lignan to women in the climacteric period as an effective drug for the prevention of the formation of immune deficiency, which contributes to the development of oncological and autoimmune diseases. The proven antitumor activity confirms the promise of using the 7-HMR for the implementation of oncopreventive measures in women of peri- and postmenopausal age. |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|